Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
Robert Croop, Richard B. Lipton, David Kudrow, David Stock, Lisa Kamen, Charles M. Conway, Elyse Stock, Vladimir Coric, Peter J. Goadsby
Topics & Concepts
MedicinePlaceboMigraineClinical endpointInternal medicineRandomized controlled trialClinical trialAdverse effectAlternative medicinePathologyMigraine and Headache StudiesNeurological Disorders and TreatmentsTraumatic Brain Injury and Neurovascular Disturbances